Vaxcyte, Inc. PCVX Increase (Decrease) In Operating Lease Right Of Use Asset
Increase (Decrease) In Operating Lease Right Of Use Asset at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept pcvx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s increase (decrease) in operating lease right of use asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s increase (decrease) in operating lease right of use asset?
- Vaxcyte, Inc. (PCVX) reported increase (decrease) in operating lease right of use asset of $0 in Q1 2026.
- How has Vaxcyte, Inc.'s increase (decrease) in operating lease right of use asset changed year-over-year?
- Vaxcyte, Inc.'s increase (decrease) in operating lease right of use asset decreased by 100.0% year-over-year, from $17.58M to $0.
- What does increase (decrease) in operating lease right of use asset mean?
- This represents the change in the carrying amount of the right-of-use asset recognized under lease accounting standards. It reflects the amortization of the asset over the lease term and adjustments for lease modifications or impairments. This metric is critical for assessing the impact of long-term lease commitments on the company's balance sheet and cash flow profile.